Cargando…
Novel plasma protein biomarkers from critically ill sepsis patients
BACKGROUND: Despite the high morbidity and mortality associated with sepsis, the relationship between the plasma proteome and clinical outcome is poorly understood. In this study, we used targeted plasma proteomics to identify novel biomarkers of sepsis in critically ill patients. METHODS: Blood was...
Autores principales: | Van Nynatten, Logan R., Slessarev, Marat, Martin, Claudio M., Leligdowicz, Aleks, Miller, Michael R., Patel, Maitray A., Daley, Mark, Patterson, Eric K., Cepinskas, Gediminas, Fraser, Douglas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792322/ https://www.ncbi.nlm.nih.gov/pubmed/36572854 http://dx.doi.org/10.1186/s12014-022-09389-3 |
Ejemplares similares
-
Novel Outcome Biomarkers Identified With Targeted Proteomic Analyses of Plasma From Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2020) -
Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers
por: Fraser, Douglas D., et al.
Publicado: (2020) -
Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2021) -
Endothelial Injury and Glycocalyx Degradation in Critically Ill Coronavirus Disease 2019 Patients: Implications for Microvascular Platelet Aggregation
por: Fraser, Douglas D., et al.
Publicado: (2020) -
Cross-immunity against SARS-COV-2 variants of concern in naturally infected critically ill COVID-19 patients
por: Fraser, Douglas D., et al.
Publicado: (2022)